GRCE
Grace Therapeutics
GRCE
GRCE
20 hedge funds and large institutions have $11.3M invested in Grace Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$456K | |
| 2 | +$67K | |
| 3 | +$7.53K | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
+$122 |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$86 |
Top Sellers
| 1 | -$576K | |
| 2 | -$496K | |
| 3 | -$43.2K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.17K |
